lobbying_activities: 2339641

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2339641	6ea7de68-8965-4213-b128-e53e4ccf37d1	Q3	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	1466	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	2019	third_quarter	MMM	On July 10, 2019 AACC wrote to Rep. Scott Peters endorsing H.R.3584, the Laboratory Access for Beneficiaries Act, which seeks to ensure that the payment amounts on the new market-based clinical laboratory fee schedule, authorized under the Protecting Access to Medicare Act (PAMA), are accurate. On August 20, 2019 ACC wrote to Rep. Judy Chu endorsing H.R.3031, which would reauthorize the National Quality Forum (NQF) through 2024 at $30 million annually.	HOUSE OF REPRESENTATIVES,SENATE		50000	0	0	2019-10-09T12:01:02.487000-04:00